SCHEMBL4354866

SCHEMBL4354866

CCOC(=O)c1sc(-c2cccc([N+](=O)[O-])c2)cc1N

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 1.00
RAB9A P51151 6/20 1.00
MEN1 O00255 5/20 1.00
KMT2A Q03164 5/20 1.00
KDM4E B2RXH2 4/20 0.72
NPC1 O15118 4/20 0.72
SMN1; SMN2 Q16637 4/20 0.72
ALDH1A1 P00352 4/20 0.72
HPGD P15428 3/20 0.72
HSD17B10 Q99714 3/20 0.72
TP53 P04637 1/20 0.62
CASP3 P42574 1/20 0.62
SENP8 Q96LD8 1/20 0.62
SENP7 Q9BQF6 1/20 0.62
SENP6 Q9GZR1 1/20 0.62
CYP1A2 P05177 1/20 0.62
CYP2C9 P11712 1/20 0.62
CYP2C19 P33261 1/20 0.62
RECQL P46063 1/20 0.62
L3MBTL1 Q9Y468 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1882680 0.84 MAPT (1.00) MAPTRAB9AMEN1KMT2AKDM4E
SCHEMBL6607594 0.82 MAPT (0.69) MAPTRAB9AMEN1KMT2AKDM4E
SCHEMBL6287361 0.80 ALDH1A1 (0.67) MAPTRAB9AMEN1KMT2AKDM4E
SCHEMBL17268776 0.79 MAPT (0.80) MAPTRAB9AMEN1KMT2AKDM4E
SCHEMBL10725054 0.77 MAPT (1.00) MAPTRAB9AMEN1KMT2AKDM4E
SCHEMBL3254787 0.77 MAPT (0.76) MAPTRAB9AMEN1KMT2AKDM4E
SCHEMBL1143359 0.77 MAPT (0.76) MAPTRAB9AMEN1KMT2AKDM4E
SCHEMBL6229303 0.76 MAPT (0.67) MAPTRAB9AMEN1KMT2AKDM4E
SCHEMBL5944038 0.74 MAPT (0.60) MAPTRAB9AMEN1KMT2ANPC1
SCHEMBL8290552 0.74 MAPT (1.00) MAPTRAB9AMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090192154-A1 SULTAM DERIVATIVES ASAHI KASEI PHARMA CORPORATION (JP) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192154-A1 SULTAM DERIVATIVES SULT1A1, SULT2A1, ADAMTS1 MAPT 948/4885RAB9A 3804/4885MEN1 2847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.